Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QiShen capsule after PCI for coronary heart disease
ChiCTR1900021058Phase 4Recruiting
- Sponsor
- Fuwai Hospital
- Start
- May 2021
- Countries
- 1
01
Overview
Phase 4, randomised trial of qishen capsule in coronary arteriosclerosis (2 arms), sponsored by Fuwai Hospital. Primary endpoints: Cardiovascular related deaths, Nonfatal myocardial infarction and 3 more. Started May 2021; status: recruiting.
02
Drugs
qishen capsule
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1900021058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021058.